Viewing Study NCT04894994


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-02-09 @ 8:14 AM
Study NCT ID: NCT04894994
Status: TERMINATED
Last Update Posted: 2023-12-05
First Post: 2021-05-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: FLX475 in Combination With Ipilimumab in Advanced Melanoma
Sponsor: RAPT Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoplasms View
None Ipilimumab View
None Antineoplastic Agents View
None Immunological View